ChemoCentryx
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ChemoCentryx's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 50% to $32,224,000. Profit margin reached -401%. Total operating expenses were $162,143,000.
Profit Margin
| 2012 | 5.41M | -39.89M | -736.13% |
|---|---|---|---|
| 2013 | 6.06M | -38.67M | -638.17% |
| 2014 | 0 | -46.92M | |
| 2015 | 0 | -47.30M | |
| 2016 | 11.43M | -39.96M | -349.48% |
| 2017 | 82.49M | 17.85M | 21.65% |
| 2018 | 42.87M | -37.96M | -88.55% |
| 2019 | 35.95M | -55.48M | -154.34% |
| 2020 | 64.89M | -55.35M | -85.31% |
| 2021 | 32.22M | -129.06M | -400.51% |
CCXI Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 32.22M | 64.89M | 35.95M | 42.87M | 82.49M | 11.43M | 0 | 0 | 6.06M | 5.41M |
Cost of revenue | 302K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 31.92M | 64.89M | 35.95M | 42.87M | 82.49M | 11.43M | 0 | 0 | 6.06M | 0 |
Operating exp. | ||||||||||
Research and development | 82.99M | 77.88M | 70.27M | 62.73M | 49.49M | 37.94M | 33.18M | 33.81M | 33.54M | 34.56M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 162.14M | 120.06M | 94.25M | 83.14M | 66.00M | 52.15M | 47.68M | 47.39M | 45.17M | 45.04M |
Operating income | -134.45M | -55.17M | -58.30M | -40.27M | 16.49M | -40.72M | -47.68M | -47.39M | -39.11M | -39.63M |
Other income (expenses), net | 2.69M | -179K | 2.81M | 2.30M | 1.36M | 757K | 384K | 470K | 442K | -261K |
Income before tax | -131.75M | -55.35M | -55.48M | -37.96M | 17.85M | -39.96M | -47.30M | -46.92M | -38.67M | -39.89M |
Income tax expense | -2.69M | 2.46M | 4.96M | 3.52M | 1.37M | 757K | 384K | 494K | 501K | 0 |
Net income | -129.06M | -55.35M | -55.48M | -37.96M | 17.85M | -39.96M | -47.30M | -46.92M | -38.67M | -39.89M |
Earnings per share | ||||||||||
Basic EPS | -1.96 | -0.84 | -0.98 | -0.76 | 0.37 | -0.86 | -1.08 | -1.08 | -0.95 | -1.13 |
Diluted EPS | -1.96 | -0.84 | -0.98 | -0.76 | 0.36 | -0.86 | -1.08 | -1.08 | -0.95 | -1.13 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |